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children admitted from 2009 to 2013 were screened for primary or secondary 
admission diagnoses of septicemia or septic shock. To characterize body habitus, 
we calculated weight-for-height Z-Score groups for children younger than 24 mo, 
and Body Mass Index (BMI)-for-age Z-Score groups for children older than 24 
mo using CDC growth curves. We constructed mixed-effects regression models 
to evaluate the association between body habitus and mortality as well as pre-
sentation severity of illness controlling for confounding variables, complex and 
non-complex chronic conditions, and hospital level effects. Results: We enrolled 
7,169 children from 53 PICUs, with an overall mortality of 10.2%. On univari-
ate analysis, children with weight-for-height or BMI-for-age Z-score groups less 
than -3.5 to -0.5, as well as greater than 3.5, had higher mortality (P ≤ 0.002). 
However, after adjusting for Pediatric Risk of Mortality (PRISM) score, presence 
of a complex chronic condition, age, race, and a diagnosis of trauma, there was 
no association between body habitus and mortality (all P ≥ 0.083). Multivariate 
modeling using PRISM score as the outcome revealed children with weight-for-
height or BMI-for-age Z-score groups less than -3.5 to -0.5, as well as greater 
than 3.5, had higher PRISM Scores compared to Z-score group -0.5 to 0.5 (P ≤ 
0.002), even after adjusting for other confounding variables including age, race, 
presence of complex chronic conditions, and trauma (P < 0.001). Conclusions: 
Underweight children and severely overweight children have higher ICU mortal-
ity which appears to be explained by higher admission severity of illness.
1009
A TISSUE PERFUSION MEASUREMENT IN CRITICALLY-ILL 
PATIENTS AS A PREDICTOR OF MORTALITY
Kiersten Norby, Laura Spector, Timothy Perkins, David Inouye, Richard Sev-
erino, Danny Takanishi, Mihae Yu
Learning Objectives: Mortality from shock remains high necessitating the need 
for continued innovations in early detection of shock. Transcutaneous PO2 
(PtcO2) changes with PaO2 and FiO2 in non-shock states, but during shock, 
PtcO2 approximates cardiac output with minimum response to increasing FiO2 
and PaO2. This response to FiO2 of 1.0 is called the Oxygen Challenge test 
(OCT) and has been shown to predict organ failure and mortality. The OCT 
can also be used as an endpoint of resuscitation. The purpose of this study was 
to determine whether there is a numeric value of OCT which is best associated 
with outcome and validate or refute findings of previous studies. Methods: The 
OCT was measured in critically-ill patients at baseline and daily. Patients pre-
dicted survival was determined by comparing their 24 hour OCT values to a 
series of reference values starting at zero and increasing by 5 point increments. 
For each reference value, predicted survival was compared to actual survival and 
the positive predictive values (PPV) and negative (NPV) were calculated with the 
optimal reference value defined as the one which yields the best combination of 
predictive values. A chi-square test was used to determine the statistical signifi-
cance of the association of the dichotomized OCT and actual survival. Results: 
Seventy-nine patients were studied. Demographics were: mean age 67 ± 16 yr, 
49 males (62%), 30 females (38%), APACHE II 25.9 ± 7.8, Septic Shock/Severe 
Sepsis 49/79 (62%), Hemorrhagic Shock 21/79 (27%), Cardiac Failure 19/79 
(24%), Respiratory Failure 60/79 (76%). Fifty-five (69.6%) of the 79 patients 
survived to discharge. An OCT value of 25 at 24 hr of resuscitation yielded a PPV 
of 83.9% and a NPV of 66.7%. Eighty-nine percent of survivors had an OCT ≥ 
25 compared to 43% of non-survivors (p<.0001). Conclusions: Measurement of 
tissue perfusion can be valuable in critically-ill patients as a predictor of survival 
and an endpoint of resuscitation. An OCT value of 25 can be used as an indicator 
of adequate tissue perfusion and may be predictive of survival.
1010
AN AUTOMATED ALGORITHM FOR THE EARLY DETECTION 
OF HEMODYNAMIC INSTABILITY IN THE PICU
Cristhian Potes, Bryan Conroy, Minnan Xu, larry Eshelman, Christopher 
Newth, Joseph Frassica
Learning Objectives: Early recognition and timely intervention are critical steps 
for the successful management of pediatric shock. However, early recognition of 
shock can be difficult and requires a high index of suspicion by the clinician. The 
aim of this study was to develop an algorithm that could assist bedside clinicians 
with the early detection of hemodynamic instability (shock) in the pediatric ICU 
(PICU). Methods: This study was done on a retrospective cohort of all patients 
admitted to a tertiary PICU at a single center. Patients were labeled as hemody-
namically unstable (n=3970) if they received a fluid bolus (i.e., administration of 
colloid or crystalloid > 10 ml/kg/hr), or blood transfusion (i.e., packed red blood 
cells > 10 ml/kg over the course of 24 hr), or any dosage of inotropic or vasopres-
sor medications. Patients were labeled as hemodynamically stable (n=7213) if 
they did not receive any of the interventions mentioned above during the entire 
PICU stay. Electronic medical records (EMR) were obtained from an electronic 
flow sheet (Philips Care-Vue, Waltham, MA) and the PICU’s own database. A 
total of 58 features were extracted from the EMR and analyzed to predict (i.e., up 
to 6 hr before) the occurrence of a hemodynamic instability event. A variant of 
AdaBoost was used to learn a set of low-dimensional classifiers, each of which was 
age-adjusted. A small subset of data were used for training and validation, while 
retrospective evaluation was performed on the entire database. Results: Among 
the 58 features initially included in the analysis, only 16 features were finally 
selected by AdaBoost. The best classification performance resulted in an area 
under ROC curve of 0.91, a sensitivity of 0.78, and a specificity of 0.88. Shock 
index was the most discriminative feature, and it was, by itself, a very good pre-
dictor of hemodynamic instability (area under ROC of 0.85). Conclusions: We 
proposed an algorithm for early detection of hemodynamic instability in PICU 
patients. This algorithm provides a risk score of hemodynamic instability, which 
can be of significant clinical value in busy PICU environments.
1011
LIPIDOMICS OF CRITICAL ILLNESS
Michael Maile, Theodore Standiford, Elizabeth Jewell, Charles Burant
Learning Objectives: A number of disease processes can result in critical illness. 
Interestingly, even when the inciting events are disparate, progression to multiple 
organ failure and death frequently appears remarkably similar. Metabolomics, by 
defining the metabolic fingerprint created by the underlying pathophysiology, 
may be helpful for identifying new biomarkers and novel therapeutic targets in 
this population. We hypothesized that changes in the plasma lipidome would 
be associated with mortality in a critically ill patient population. Methods: The 
plasma lipidome of 30 critically ill individuals was measured at two time points 
using liquid chromatography-mass spectrometry. Pooled samples and internal 
standards were also included. Compounds were identified by matching peaks in 
the resulting mass spectrum to known lipids in the LipidBlast database. Concen-
trations were normalized using internal standards and adjusted for batch effects 
using loess smoothing. Those with missing values, a relative standard deviation in 
the upper decile in the pooled samples, or a median concentration in the lowest 
decile were removed. Lipids that differed between survivors and non-survivors 
were identified using the multivariate empirical Bayes approach. This data reduc-
tion was performed with auto scaled values using MetaboAnalyst 3.0. Top fea-
tures (those with the highest Hotelling-T2 values) were then compared using 
Student’s t-test and two-way analysis of variance using SAS 9.3. Results: Triacyl-
glycerols (TGs) consisting primarily of polyunsaturated fatty acids accounted for 
ten of the twelve lipids that differed most between survivors and non-survivors. 
These TGs did not demonstrate a consistent and significant within-subject varia-
tion over time. However, survivors did have significantly higher levels of all ten of 
these compounds. Concentrations were between 2.44 and 4.09 times higher in 
the survivor cohort and p-values ranged from 0.0002 to <0.0001. Conclusions: 
Triacylglycerols with a high number of polyunsaturated fatty acids may be useful 
for predicting mortality in critically ill patients.
1012
AGREEMENT BETWEEN PERIPHERAL VENOUS, CENTRAL 
VENOUS, AND ARTERIAL LACTATE
Caleb Hsieh, Tristan Grogan, Nader Kamangar, Richard Treger
Learning Objectives: Arterial lactate (a-lac) is considered the criterion stan-
dard for lactate determination, but arterial sampling is invasive and carries risks. 
Venous lactate values, especially peripheral venous lactate (pv-lac), have been con-
sidered less reliable; nonetheless their use in clinical practice has increased. The 
objective of this study was to examine agreement between pv-lac, central venous 
lactate (cv-lac), and a-lac values in a population of medical Intensive Care Unit 
(ICU) patients, with an emphasis on agreement at high lactate values (a-lac > 4 
Copyright © 2015 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
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mmol/L). Methods: A single-center, prospective trial was conducted with adult 
patients in a medical ICU. Patients with an existing peripheral venous line, cen-
tral venous line and arterial line were enrolled. Arterial, central and peripheral 
venous samples were obtained within 10 min of each other. A single blood gas 
analyzer was used to measure lactate. Bland-Altman plots were used to evalu-
ate agreement. Pearson correlations between a-lac and v-lac were generated and 
linear regression was used to derive equations for estimation of a-lac from both 
pv-lac and cv-lac. Results: 23 patients were included with a total of 54 paired 
arterial and venous (pv and cv) samples and 9 a-lac values > 4 mmol/L. A linear 
mixed effects model indicated that all 54 observations could be reasonably com-
bined. The mean difference for a-lac minus pv-lac and a-lac minus cv-lac was 
-0.17 and 0.054, respectively. Bland-Altman plots of a-lac and pv-lac, as well as 
a-lac and cv-lac showed 95% limits of agreement of -1.17 to 0.82 and -0.75 to 
0.86, respectively. Regression equations were derived as follows: a-lac = -0.164 
+ 0.998 × pv-lac and a-lac = 0.077 + 0.992 × cv-lac. The R2 was 0.93 and 0.95, 
respectively, although it decreased to 0.60 and 0.65 for a-lac values > 4 mmol/L. 
Conclusions: Both pv-lac and cv-lac showed strong agreement and high correla-
tion with a-lac, and although the relationship is less robust at high lactate values, 
it would not likely affect clinical management. Pv-lac or cv-lac can replace a-lac 
in most clinical contexts encountered in the ICU.
1013
VALIDATION OF THE VASOACTIVE INOTROPIC SCORE IN 
PEDIATRIC SEPSIS
Amanda McIntosh, Sarah Schmidt, Suhong Tong, Sara Deakyne, Jesse David-
son, Halden Scott
Learning Objectives: Pediatric sepsis is common and has significant associated 
morbidity and cost. Vasoactive and inotropic medications are often necessary for 
cardiovascular support. In infants undergoing cardiac surgery, the vasoactive ino-
tropic score (VIS) correlates well with important clinical outcomes and is the 
standard scoring system for cardiovascular support in that population. Limited 
data exist to support the use of VIS outside of infant cardiac surgery. This study 
was performed to assess the validity of VIS as a scoring system for cardiovascular 
support in pediatric sepsis. Methods: This is a secondary analysis of a prospective, 
single-center sepsis registry. It included children with sepsis clinically identified 
in the emergency department from 1/12–6/15 who were treated with at least 
one vasoactive agent in the first 48 hr. VIS was abstracted at 6, 12, 24, and 48 hr 
post ICU admission. Primary outcomes were ventilator days and ICU length of 
stay (LOS). Secondary outcomes were endotracheal intubation and combined 
cardiac arrest/ECMO/in-hospital mortality. Results: A total of 139 patients 
met inclusion criteria. The most common underlying diagnoses were genetic/
metabolic (21.6%) and previously healthy (23%) and the most common infec-
tious sources were pneumonia (31.7%) and bacteremia (23%). One third were 
intubated during their stay and mortality was 5%. On univariate analysis, VIS 
at 48hr after PICU arrival ranged from 0 to 45 and correlated most strongly 
with ICU LOS (r=0.53; p<0.0001) and ventilator days (r=0.52;p<0.0001). On 
multivariate analysis, VIS at 48hr remained a strong independent predictor of 
both ICU LOS (p<0.0001) and ventilator days (p<0.0001). Logistic regression 
demonstrated increased odds of intubation and combined ECMO, cardiac arrest, 
or death with each unit increase in VIS at 48hr (1.19, p<0.0005 and 1.08, p<0.05 
respectively).Conclusions: This study suggests that a higher VIS score at 48 hr 
from ICU arrival in pediatric sepsis patients is a predictor for increased ICU LOS, 
ventilator days, and combined poor outcome.
1014
ABO BLOOD TYPE A AND INCREASED SEVERITY  
OF SEPSIS
Hani Kuttab, Collette Williams, Andrew Wilson, Michael Murphy,  
Megan Rech
Learning Objectives: Blood type A has been linked to increased susceptibility 
of infection, inflammatory vascular disease, and most recently, risks of acute 
lung injury and ARDS in patients with severe sepsis. It is unknown if blood 
type A is associated with an increased risk of organ dysfunction secondary to 
septic shock. This study evaluated the progression through multi-organ failure 
secondary to sepsis in patients with blood type A compared to other blood types. 
Methods: This is a retrospective cohort study conducted at an urban, academic 
tertiary care center. Patients 18 yr and older admitted between January 1, 2010 
and March 1, 2014 with a diagnosis of sepsis and a documented blood type were 
included. The following points were collected: baseline demographics, severe sep-
sis or septic shock diagnosis, Acute Physiology and Chronic Health Evaluation II 
(APACHE II) score, comorbidities, sepsis source, serum lactate, hospital length 
of stay (LOS), and mortality. Sequential Organ Failure Assessment (SOFA) scores 
were assigned to groups on days 1 and 3. Univariate analysis with Chi-square, 
Fisher’s exact test, or t-test was performed. Multivariate regression analysis was 
conducted. Results: Of the 538 patients in this study, 303 had blood type A and 
235 had non-A blood types. Baseline demographics and comorbidities were well 
matched between groups, with the exception of history of stroke (7.7% type A 
vs. 2.6% other, p=0.007). Blood type A patients had higher baseline APACHE II 
scores (24.33 vs. 22.76, p=0.025), higher SOFA scores on day 3 (6.30 vs. 4.64, 
p <0.001), and less reduction in SOFA scores between day 1 and day 3 (1.81 
vs. 3.38, p <0.001). No differences in LOS and in-hospital, 30-day, or 90-day 
mortality were observed. A multivariate analysis demonstrated that patients with 
blood type A had higher SOFA scores on day 3 (p=0.003) and that the absolute 
difference in SOFA scores between day 1 and 3 was lower in patients with blood 
type A (p=0.007). Conclusions: Patients with blood type A had higher severity 
of illness and delayed recovery from sepsis-induced organ failure when compared 
to other blood types.
1015
RETICULOENDOTHELIAL DYSFUNCTION IS CENTRAL  
IN DIAGNOSING ADULT MACROPHAGE ACTIVATION  
SYNDROME
Bita Shakoory, Negin Mohtasham, Richard Amdur, Matthew Mullen, Steven 
Opal, Winn Chatham
Learning Objectives: Macrophage activation syndrome is poorly defined in 
adults; comorbidities, low index of suspicion, and lack of validated diagnostic cri-
teria in adults limits the early recognition of MAS. This study uses an established 
adult MAS cohort and respective controls to identify system-based predictors of 
adult MAS, to propose a preliminary diagnostic criteria for MAS in adults, and to 
examine the association between MAS and outcomes [death, critical care, length 
of stay(LOS)]. Methods: Using a retrospective, observational study design, adults 
with MAS and respective controls were identified among patients with ferritin 
above 2000 ng/dL during hospital admission at a single academic center between 
January 2009 and December 2012. MAS Cases: those with 5/8 of the HLH-2004 
or ≥4/5 adapted HLH criteria, those whose treatment was specifically initiated 
or adjusted for a diagnosis of MAS. Two age and gender matched controls were 
selected for each case. Patients with >2 elements of adapted HLH criteria missing, 
outpatient evaluation, chronic transfusion and chronic hemolytic disorders were 
excluded. Univariate and multivariate analysis with logistic regression testing, t 
test and chi square was used for analysis. Results: Study subjects: 60 MAS cases 
(mean age 42, 66% women, 60% non-white) and 76 controls (mean age 45, 
69% women, 51% non-white). Univariate analysis: MAS compared to non-MAS 
experienced more cardiovascular (p=.005), respiratory (p=.0006), hepatobiliary 
(HBD; p=0.017) dysfunction, coagulation (DIC; p<.0001), infection (p=.007), 
ferritin>4,500ng/dL. The logistic model prediction of MAS had strong discrimi-
nation (c>.90), sensitivity and specificity of .84 and .88 respectively using predic-
tors HBD, DIC, Ferretin>4500 ng/dl. Death occurred in 50% of MAS vs 22% 
of non-MAS (p=.0001); 71% of MAS required critical care vs. 46% of non-MAS 
(p=.0034); median LOS was 19 in MAS (IQR 11–30) vs. 11 in non-MAS (IQR 
5–25). Conclusions: MAS in adults results in higher mortality, higher need for 
critical intervention, longer stay. Presence of MAS should be suspected in patients 
with HBD, DIC, ferritin >4,500 ng/dL.
1016
CLINICAL SIGNIFICANCE OF SERIAL CHANGES IN PLASMA 
SURFACTANT PROTEIN D IN PATIENTS WITH SEPSIS
Jinkyeong Park, Youjin Chang, Jeongwon Heo, Mi Kyoung Hong,  
Chi Ryang Chung, Jeong Hoon Yang, Chi Min Park, Gee Young Suh
Learning Objectives: Acute respiratory distress syndrome (ARDS) is a heteroge-
neous entity. Surfactant protein D (SPD) suggested discrimination for diagnosis 
